Baltimore, MD – According to filings with the U.S. Securities and Exchange Commission, Vita Therapeutics is raising $30,892,998.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Douglas Falk played a…
Baltimore, MD – According to filings with the U.S. Securities and Exchange Commission, Vita Therapeutics is raising $11,999,992.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Douglas Falk played a…
Baltimore, MD – According to filings with the U.S. Securities and Exchange Commission, Vita Therapeutics is raising $20,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Douglas Falk played a…